This suggests that healthcare providers can use a dose-titration strategy to achieve the balance between weight-loss efficacy and tolerability for individual patients
GLP-1 medications are FDA-approved for type 2 diabetes management and, at higher doses, for chronic weight management in adults with obesity or overweight with weight-related comorbidities
Tirzepatide works on GLP-1 and GIP pathways, while Semaglutide works through GLP-1 pathways
The key principle to understand is that semaglutide side effects are most pronounced at the moment of dose escalation and progressively diminish as the body adjusts
The mean calorie intake was 1,748 kcal/day for the overall sample, 1,700 kcal/day for females, and 1,933 kcal/day for males
Start with lower-sulfur options first (small amounts of cooked broccoli, for example) and work up to the bigger triggers (eggs, garlic)